pubmed.ncbi.nlm.nih.gov

In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation - PubMed

In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation

Björn Bauer et al. Mol Pharmacol. 2006 Oct.

Abstract

The ATP-driven drug export pump, P-glycoprotein, is a primary gatekeeper of the blood-brain barrier and a major impediment to central nervous system (CNS) pharmacotherapy. Reducing P-glycoprotein activity dramatically increases penetration of many therapeutic drugs into the CNS. Previous studies in rat showed that brain capillary P-glycoprotein was transcriptionally up-regulated by the pregnane X receptor (PXR), a xenobiotic-activated nuclear receptor. Here we used a transgenic mouse expressing human PXR (hPXR) to determine the consequences of increased blood-brain barrier P-glycoprotein activity. P-glycoprotein expression and transport activity in brain capillaries from transgenic mice was significantly increased when capillaries were exposed to the hPXR ligands, rifampin and hyperforin, in vitro and when the mice were dosed with rifampin in vivo. Plasma rifampin levels in induced mice were comparable with literature values for patients. We also administered methadone, a CNS-acting, P-glycoprotein substrate, to control and rifampin-induced transgenic mice and measured the drug's antinociceptive effect. In rifampin-induced mice, the methadone effect was reduced by approximately 70%, even though plasma methadone levels were similar to those found in transgenic controls not exposed to rifampin. Thus, hPXR activation in vivo increased P-glycoprotein activity and tightened the blood-brain barrier to methadone, reducing the drug's CNS efficacy. This is the first demonstration of the ability of blood-brain barrier PXR to alter the efficacy of a CNS-acting drug.

PubMed Disclaimer

Cited by

Regulation of ABC transporters at the blood-brain barrier.
Miller DS. Miller DS. Clin Pharmacol Ther. 2015 Apr;97(4):395-403. doi: 10.1002/cpt.64. Epub 2015 Jan 20. Clin Pharmacol Ther. 2015. PMID: 25670036 Free PMC article. Review.
Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.
Ma JD, Tsunoda SM, Bertino JS Jr, Trivedi M, Beale KK, Nafziger AN. Ma JD, et al. Clin Pharmacokinet. 2010 Apr;49(4):223-37. doi: 10.2165/11318000-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20214407 Review.
Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
Vulin M, Zhong Y, Maloney BJ, Bauer B, Hartz AMS. Vulin M, et al. Fluids Barriers CNS. 2023 Oct 6;20(1):70. doi: 10.1186/s12987-023-00470-z. Fluids Barriers CNS. 2023. PMID: 37803468 Free PMC article.
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.
Kharasch ED, Francis A, London A, Frey K, Kim T, Blood J. Kharasch ED, et al. Clin Pharmacol Ther. 2011 Jul;90(1):100-8. doi: 10.1038/clpt.2011.59. Epub 2011 May 11. Clin Pharmacol Ther. 2011. PMID: 21562488 Free PMC article.
Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.
Wang X, Campos CR, Peart JC, Smith LK, Boni JL, Cannon RE, Miller DS. Wang X, et al. J Neurosci. 2014 Jun 18;34(25):8585-93. doi: 10.1523/JNEUROSCI.2935-13.2014. J Neurosci. 2014. PMID: 24948812 Free PMC article.

In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation - PubMed